High levels of platelet-monocyte aggregates after valve replacement for aortic stenosis: relation to soluble P-selectin and P-selectin glycoprotein ligand-1 genes

Thromb Res. 2012 Apr;129(4):453-8. doi: 10.1016/j.thromres.2011.07.021. Epub 2011 Aug 3.

Abstract

Background: Calcific aortic valve stenosis is linked to atherosclerosis. The latter is associated with increased levels of platelets adhering to monocytes (PMA).

Objective: The hemodynamic impairment in symptomatic aortic valve stenosis can be abated by valve replacement. We investigated the effect of valve replacement on PMA and receptor-ligand axis P-selectin - P-selectin glycoprotein ligand-1 (PSGL-1) in severe aortic valve stenosis.

Patients and methods: PMA, plasma P-selectin (sP-selectin) and polymorphisms within the coding region for PSGL-1 (SELPLG) were determined in 42 patients with severe aortic valve stenosis before and 4 to 8 months after valve replacement. Ten patients suffered from significant coronary artery disease and received also a coronary artery bypass graft. Thirty-four patients received a bioprosthetic valve and 8 patients who were <65 years old received a mechanical valve.

Results: Before the intervention, PMA levels were significantly higher in patients with aortic valve stenosis than in two control cohorts, namely healthy indviduals and 88 age- and sex-matched patients with severe atherosclerosis, but without aortic valve stenosis (p<0.001). PMA decreased after surgery, but normalized in only 3 patients, while further increases were noted in 11 patients. sP-selectin was elevated in 3 and 4 patients before and after valve replacement, respectively. sP-selectin increased significantly after surgery, but remained within the normal range. There was no correlation between changes of PMA and sP-selectin or any of the polymorphisms within SELPLG.

Conclusions: Exceedingly high PMA in aortic stenosis are independent of SELPLG polymorphisms, and largely of the hemodynamic compromise caused by the stenotic valve.

Publication types

  • Controlled Clinical Trial

MeSH terms

  • Aged
  • Aortic Valve Stenosis / blood*
  • Aortic Valve Stenosis / pathology
  • Aortic Valve Stenosis / surgery*
  • Female
  • Heart Valve Prosthesis*
  • Humans
  • Male
  • Membrane Glycoproteins / blood*
  • Monocytes / metabolism*
  • Monocytes / pathology
  • P-Selectin / blood*
  • P-Selectin / chemistry
  • Platelet Aggregation*
  • Solubility
  • Treatment Outcome

Substances

  • Membrane Glycoproteins
  • P-Selectin
  • P-selectin ligand protein